Fund Holdings — KVP Capital Advisors, LP

Total Portfolio Value:
$124.29M
Total Bought:
$124.29M
Total Sold:
$0
Net Transaction:
+$124.29M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Praxis Precision Medicines, Inc.(PRAX)042,900+42,900$0$12.49M10.05%+$12.49M
Whitehawk Therapeutics Inc02,165,997+2,165,997$0$8.14M6.55%+$8.14M
Silence Therapeutics plcADS(SLN)0684,123+684,123$0$7.48M6.02%+$7.48M
Protagonist Therapeutics Inc053,000+53,000$0$7.47M6.01%+$7.47M
MBX Biosciences, Inc.(MBX)0121,524+121,524$0$7.12M5.73%+$7.12M
Erasca, Inc.(ERAS)0455,000+455,000$0$6.67M5.37%+$6.67M
Trevi Therapeutics, Inc.(TRVI)0414,000+414,000$0$5.93M4.77%+$5.93M
Tango Therapeutics, Inc.(TNGX)0230,264+230,264$0$5.75M4.62%+$5.75M
Edgewise Therapeutics, Inc.(EWTX)0133,000+133,000$0$5.40M4.34%+$5.40M
Tandem Diabetes Care, Inc.(TNDM)0301,000+301,000$0$4.91M3.95%+$4.91M
Achieve Life Sciences Inc0462,355+462,355$0$3.74M3.01%+$3.74M
Sutro Biopharma Inc0226,575+226,575$0$3.65M2.94%+$3.65M
Insmed Incorporated(INSM)028,497+28,497$0$3.25M2.62%+$3.25M
Savara Inc.(SVRA)0605,280+605,280$0$3.12M2.51%+$3.12M
Arrivent Biopharma Inc0102,000+102,000$0$3.09M2.48%+$3.09M
IDEAYA Biosciences, Inc.(IDYA)079,700+79,700$0$3.06M2.46%+$3.06M
Disc Medicine, Inc.(IRON)043,750+43,750$0$2.86M2.30%+$2.86M
United Therapeutics Corporation(UTHR)04,750+4,750$0$2.57M2.07%+$2.57M
Viridian Therapeutics, Inc.(VRDN)0125,000+125,000$0$2.57M2.07%+$2.57M
Immix Biopharma Inc0230,423+230,423$0$2.40M1.93%+$2.40M
Design Therapeutics Inc0185,000+185,000$0$2.33M1.87%+$2.33M
Ocular Therapeutix, Inc.(OCUL)0300,000+300,000$0$2.30M1.85%+$2.30M
Travere Therapeutics, Inc.(TVTX)039,000+39,000$0$2.30M1.85%+$2.30M
Mineralys Therapeutics, Inc.(MLYS)084,168+84,168$0$2.12M1.70%+$2.12M
Vogenx Inc086,069+86,069$0$1.96M1.58%+$1.96M
Nektar Therapeutics(NKTR)026,900+26,900$0$1.63M1.31%+$1.63M
Bright Minds Biosciences Inc031,813+31,813$0$1.58M1.28%+$1.58M
Zura Bio LtdCL A0373,128+373,128$0$1.55M1.25%+$1.55M
Artiva Biotherapeutics Inc0200,000+200,000$0$1.42M1.15%+$1.42M
Evolus Inc0150,000+150,000$0$1.20M0.97%+$1.20M
Vera Therapeutics, Inc.CL A(VERA)032,700+32,700$0$1.06M0.85%+$1.06M
Cabaletta Bio Inc0505,431+505,431$0$970.4K0.78%+$970.4K
Adial Pharmaceuticals Inc0210,256+210,256$0$843.1K0.68%+$843.1K
Compass Therapeutics Inc0771,000+771,000$0$801.8K0.65%+$801.8K
Celcuity Inc.(CELC)04,000+4,000$0$318.1K0.26%+$318.1K
Yarrow Bioscience Inc010,011+10,011$0$225.4K0.18%+$225.4K
Page 1 of 1
KVP Capital Advisors, LP — 13F Holdings — Q3 2026 | TickerTrail